These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 1152675)
1. Effect of contraceptive steroids on arginine-stimulated glucagon and insulin secretion in women: I-Lipid physiology. Beck P; Eaton RP; Arnett DM; Alsever RN Metabolism; 1975 Sep; 24(9):1055-65. PubMed ID: 1152675 [TBL] [Abstract][Full Text] [Related]
2. Effect of contraceptive steroids on arginine- stimulated glucagon and insulin secretion in women. II. Carbohydrate and lipid physiology in insulin-dependent diabetics. Beck P; Arnett DM; Alsever RN; Eaton RP Metabolism; 1976 Jan; 25(1):23-31. PubMed ID: 1246206 [TBL] [Abstract][Full Text] [Related]
3. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring. Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404 [TBL] [Abstract][Full Text] [Related]
4. Mutual modification of glucose-stimulated serum insulin responses in female rhesus monkeys by ethinyl estradiol and nortestosterone derivatives. Beck P; Venable RL; Hoff DL J Clin Endocrinol Metab; 1975 Jul; 41(1):44-53. PubMed ID: 50326 [TBL] [Abstract][Full Text] [Related]
5. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles. Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353 [TBL] [Abstract][Full Text] [Related]
6. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives. Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059 [TBL] [Abstract][Full Text] [Related]
7. Effect of contraceptive steroids on arginine-stimulated glucagon and insulin secretion in women. III. Medroxyprogesterone acetate. Beck P; Zimmerman DE; Eaton RP Metabolism; 1977 Nov; 26(11):1193-8. PubMed ID: 909395 [TBL] [Abstract][Full Text] [Related]
8. Effect of oral contraceptives on plasma glucose, insulin, and glucagon levels. Gossain VV; Sherma NK; Michelakis AM; Rovner DR Am J Obstet Gynecol; 1983 Nov; 147(6):618-23. PubMed ID: 6356926 [TBL] [Abstract][Full Text] [Related]
9. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins. Goldzieher JW; de la Peña A; Chenault CB; Cervantes A Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928 [TBL] [Abstract][Full Text] [Related]
10. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162 [TBL] [Abstract][Full Text] [Related]
11. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment. Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073 [TBL] [Abstract][Full Text] [Related]
12. Effect of long-term triphasic oral contraceptive use on glucose tolerance and insulin secretion. Gillespy M; Notelovitz M; Ellingson AB; Khan FY Obstet Gynecol; 1991 Jul; 78(1):108-14. PubMed ID: 2047050 [TBL] [Abstract][Full Text] [Related]
13. Insulin resistance, secretion, and metabolism in users of oral contraceptives. Godsland IF; Walton C; Felton C; Proudler A; Patel A; Wynn V J Clin Endocrinol Metab; 1992 Jan; 74(1):64-70. PubMed ID: 1530790 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of hypertriglyceridaemia associated with contraceptive steroids. Kissebah AH; Harrigan P; Wynn V Horm Metab Res; 1973 May; 5(3):184-90. PubMed ID: 4351691 [No Abstract] [Full Text] [Related]
15. Prospective study of carbohydrate metabolism in women using a triphasic oral contraceptive containing norethindrone and ethinyl estradiol for 3 months. Spellacy WN; Ellingson AB; Kotlik A; Tsibris JC Am J Obstet Gynecol; 1988 Oct; 159(4):877-9. PubMed ID: 3052079 [TBL] [Abstract][Full Text] [Related]
16. Control of fertility with oral medication. Diddle AW; Watts GF; Gardner WH; Williamson PJ West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556 [TBL] [Abstract][Full Text] [Related]
17. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial. Notelovitz M; Kitchens CS; Khan FY Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974 [TBL] [Abstract][Full Text] [Related]
18. The effect of oral contraceptive treatment on the serum concentration of dehydroisoandrosterone sulfate. Madden JD; Milewich L; Parker CR; Carr BR; Boyar RM; Mac Donald PC Am J Obstet Gynecol; 1978 Oct; 132(4):380-4. PubMed ID: 152061 [TBL] [Abstract][Full Text] [Related]
19. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499 [TBL] [Abstract][Full Text] [Related]
20. Comparison of ethinylestradiol and mestranol in sequential-type oral contraceptives in their effects on blood glucose and serum insulin in oral glucose tolerance tests. Leis D; Botterman P; Ermler R; Maurer U Fertil Steril; 1977 Jul; 28(7):737-40. PubMed ID: 872954 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]